Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961

NCT04495140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: [14C]PF-06882961, 50 mg
DRUG: PF-06882961, 50 mg and [14C]PF-06882961, 100 ug

Sponsor

Pfizer